Human effector T cells have been difficult to isolate and characterize due to their phenotypic and functional similarity to the memory subset. In this study, a biochemical approach was used to analyze human effector CD4 T cells generated in vitro by activation with anti-CD3 and autologous monocytes for 3 to 5 days. The resultant effector cells expressed the appropriate activation/differentiation markers and secreted high levels of interferon ␥ (IFN-␥) when restimulated. Biochemically, effector CD4 T cells exhibited increases in total intracellular tyrosine phosphorylation and effector-associated phosphorylated species. Paradoxically, these alterations in tyrosine phosphorylation were concomitant with greatly reduced expression of CD3 and CD3⑀ signaling subunits coincident with a reduction in surface T-cell receptor (TCR) expression. Because loss of CD3 has also been detected in T cells isolated ex vivo from individuals with cancer, chronic viral infection, and autoimmune diseases, the requirements and kinetics of CD3 down-regulation were examined. The loss of CD3 expression persisted throughout the course of effector T-cell differentiation, was reversible on removal from the activating stimulus, and was modulated by activation conditions. These biochemical changes occurred in effector T cells generated from naive or memory CD4 T-cell precursors and distinguished effector from memory T cells. The results suggest that human effector T-cell differentiation is accompanied by alterations in the TCR signal transduction and that loss of CD3 expression may be a feature of chronic T-cell activation and effector gen-
IntroductionThe initiation of adaptive immune responses depends on the activation and differentiation of naive T cells into effector cells that migrate to antigenic sites to orchestrate immune-mediated antigen clearance. Effector T cells can also predominate in diseases characterized by chronic immune activation, such as the autoimmune diseases systemic lupus erythematosus (SLE) 1 and rheumatoid arthritis, 2 and chronic viral infections, 3 and during acute rejection of transplanted tissue. 4 Thus, characterization of the effector T-cell subset at the mechanistic level is essential to understand its role in normal and pathologic immune states.Effector T-cell differentiation involves a series of profound cellular and molecular changes, including an increase in size, up-regulation of activation/differentiation markers such as CD69, CD25, and CD45RO, 5 transcription of effector cytokine genes such as interferon ␥ (IFN-␥) and interleukin-4 (IL-4), 6 and reconfiguring of chromatin structure in the regions of these differentially expressed genes. 7 In contrast to naive CD4 T-cell precursors, the resultant effector CD4 T cells produce high levels of effector cytokines, can be reactivated in the absence of costimulation, 8,9 and exhibit an increased susceptibility to apoptosis. 8 The disparate functions and activation requirements of effector and naive CD4 T cells suggest that distinct signals are being transduced th...